TRENTON –Acting Attorney General Matthew J. Platkin today announced that New Jersey has joined with 49 other states, Washington, D.C., Puerto Rico, and the federal government to settle allegations of fraud against Mallinckrodt ARD, LLC (formerly known as Questcor Pharmaceuticals, Inc.), a U.S. subsidiary of the Irish pharmaceutical company Mallinckrodt plc (collectively Mallinckrodt), which sells and markets pharmaceutical products throughout the nation. Mallinckrodt’s U.S. headquarters is located in Bedminster, New Jersey. The total value of the settlement is $233,707,865.18, plus interest, to be paid over a period of seven years. Of this amount, New Jersey will receive nearly $2.8 million.
“Mallinckrodt cheated the Medicaid program and taxpayers alike when it attempted to profit by manipulating the system,” said Acting Attorney General Platkin. “We are committed to continuing our work with law enforcement agencies at all levels to bring justice to this type of healthcare fraud.”
“Let this settlement serve as a warning for companies looking to defraud New Jersey’s Medicaid program,” said Insurance Fraud Prosecutor Tracy M. Thompson. “The Office of the Insurance Fraud Prosecutor is committed to safeguarding taxpayers and protecting public funds by ensuring companies meet their obligations under the Medicaid Drug Rebate Program.”
The settlement resolves allegations that from January 1, 2013, through June 30, 2020, Mallinckrodt knowingly underpaid Medicaid rebates due for...
The visual verification might not be accessible to you. We recommend you to use the audio verification instead. Important: after clicking play, you will hear 6 digits. Please wait until the audio f...